111 related articles for article (PubMed ID: 1208558)
21. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
[TBL] [Abstract][Full Text] [Related]
22. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
23. Hydralazine reduces elevated sleep apnea index in spontaneously hypertensive (SHR) rats to equivalence with normotensive Wistar-Kyoto rats.
Carley DW; Trbovic SM; Radulovacki M
Sleep; 1996 Jun; 19(5):363-6. PubMed ID: 8843525
[TBL] [Abstract][Full Text] [Related]
24. [Antihypertensive effects of SA446, hydralazine and the combination on renal hypertensive rats and spontaneously hypertensive rats by long-term treatment].
Nakata K; Nishimura K; Takada T; Yamauchi H; Iso T
Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):113-21. PubMed ID: 3699625
[TBL] [Abstract][Full Text] [Related]
25. Effects of captopril and hydralazine on progression of adriamycin nephropathy in spontaneously hypertensive rats.
Djukanovic L; Susic D; Jovanovic D; Varagic J; Jovanovic D; Starcevic A; Kartaljevic G; Bogdanovic G
Isr J Med Sci; 1994 Oct; 30(10):742-6. PubMed ID: 7960685
[TBL] [Abstract][Full Text] [Related]
26. Hypertension: a controllable disease.
Freis ED
Clin Pharmacol Ther; 1972; 13(5):627-32. PubMed ID: 5053807
[No Abstract] [Full Text] [Related]
27. Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension.
Smeda JS; Lee RM; Forrest JB
Circ Res; 1988 Sep; 63(3):534-42. PubMed ID: 3409485
[TBL] [Abstract][Full Text] [Related]
28. The effect of long-term antihypertensive treatment on medial hypertrophy of cerebral arteries in spontaneously hypertensive rats.
Ibayashi S; Ogata J; Sadoshima S; Fujii K; Yao H; Fujishima M
Stroke; 1986; 17(3):515-9. PubMed ID: 3715953
[TBL] [Abstract][Full Text] [Related]
29. Cardiac mass and peripheral vascular structure in hydralazine-treated spontaneously hypertensive rats.
Jespersen LT; Nyborg NC; Pedersen OL; Mikkelsen EO; Mulvany MJ
Hypertension; 1985; 7(5):734-41. PubMed ID: 4030043
[TBL] [Abstract][Full Text] [Related]
30. [Antihypertensive agents. Interesting results with rats].
Tidsskr Nor Laegeforen; 1973 Sep; 93(27):2040. PubMed ID: 4766385
[No Abstract] [Full Text] [Related]
31. The influence of antihypertensive therapy on cerebral autoregulation in aged hypertensive rats.
Hoffman WE; Miletich DJ; Albrecht RF
Stroke; 1982; 13(5):701-4. PubMed ID: 7123604
[TBL] [Abstract][Full Text] [Related]
32. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
Gillies LK; Lu M; Wang H; Lee RM
Hypertension; 1997 Dec; 30(6):1471-8. PubMed ID: 9403569
[TBL] [Abstract][Full Text] [Related]
33. Influence of anti-hypertensive drug treatment on vascular reactivity in spontaneously hypertensive rats.
Hamilton TC
Br J Pharmacol; 1975 Aug; 54(4):429-36. PubMed ID: 1174760
[TBL] [Abstract][Full Text] [Related]
34. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
Minami N; Head GA
J Hypertens; 1993 May; 11(5):523-33. PubMed ID: 8390524
[TBL] [Abstract][Full Text] [Related]
35. Effects of antihypertensive drugs on antioxidant enzyme activities and renal function in stroke-prone spontaneously hypertensive rats.
Shou I; Wang LN; Suzuki S; Fukui M; Tomino Y
Am J Med Sci; 1997 Dec; 314(6):377-84. PubMed ID: 9413342
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats.
Tsotetsi OJ; Woodiwiss AJ; Netjhardt M; Qubu D; Brooksbank R; Norton GR
Hypertension; 2001 Oct; 38(4):846-51. PubMed ID: 11641297
[TBL] [Abstract][Full Text] [Related]
37. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
38. Prevention of hypertensive hypertrophy by medical therapy: effects on systolic wall stress and systolic function.
Motz W; Strauer BE
Basic Res Cardiol; 1985; 80(6):642-52. PubMed ID: 2936329
[TBL] [Abstract][Full Text] [Related]
39. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR.
Welch WJ; Wilcox CS
Kidney Int; 2001 Apr; 59(4):1257-63. PubMed ID: 11260386
[TBL] [Abstract][Full Text] [Related]
40. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
Christensen KL; Jespersen LT; Mulvany MJ
J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
